Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Julie Z. Zhao"'
Publikováno v:
Kidney Medicine, Vol 5, Iss 1, Pp 100564- (2023)
Rationale & Objective: Information regarding disparities in initiating sodium/glucose cotransporter 2 inhibitors (SGLT2i) and glucagon-like peptide 1 receptor agonists (GLP-1RA) in patients with chronic kidney disease (CKD) is limited. We examined so
Externí odkaz:
https://doaj.org/article/7c3ec53b95f94562b4df26b17c87140e
Publikováno v:
Kidney Medicine, Vol 4, Iss 8, Pp 100510- (2022)
Rationale & Objective: Information on safety issues of newer glucose-lowering medications from a large population perspective in chronic kidney disease (CKD) patients with type 2 diabetes is limited. Our study aimed to examine hypoglycemia risk assoc
Externí odkaz:
https://doaj.org/article/02d242b52008481fa9d9c79031f07675
Publikováno v:
Kidney Medicine, Vol 3, Iss 2, Pp 173-182.e1 (2021)
Background: Information regarding the use of glucose-lowering medications in patients with chronic kidney disease (CKD) is limited. Study Design: Retrospective cohort study. Setting & Participants: Medicare 5% random sample of patients with CKD with
Externí odkaz:
https://doaj.org/article/3e6a6fe6021b47b2a237902bb31dd804
Publikováno v:
Journal of wound, ostomy, and continence nursing : official publication of The Wound, Ostomy and Continence Nurses Society. 49(5)
The primary purpose of this study was to evaluate the impact of a patient-centered, chronic care self-management support program of clean intermittent catheterization (CIC) on emergency department (ED) visits and hospitalizations within the first 30
Publikováno v:
Kidney Medicine
Background Information regarding the use of glucose-lowering medications in patients with chronic kidney disease (CKD) is limited. Study Design Retrospective cohort study. Setting & Participants Medicare 5% random sample of patients with CKD with typ
Autor:
Hasan SA; Shaquib Al Hasan, MS, Social and Administrative Pharmacy Graduate Program, Department of Pharmaceutical Care and Health Systems, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota.; Levi Neal-Herman, MBA, Coloplast Care, Coloplast Corp, Minneapolis, Minnesota.; Holly S. Norman, PhD, Coloplast Corp, Minneapolis, Minnesota.; Julie Z. Zhao, MPH, Department of Pharmaceutical Care and Health Systems, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota.; Angeline Carlson, PhD, Department of Pharmaceutical Care and Health Systems, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota., Neal-Herman L; Shaquib Al Hasan, MS, Social and Administrative Pharmacy Graduate Program, Department of Pharmaceutical Care and Health Systems, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota.; Levi Neal-Herman, MBA, Coloplast Care, Coloplast Corp, Minneapolis, Minnesota.; Holly S. Norman, PhD, Coloplast Corp, Minneapolis, Minnesota.; Julie Z. Zhao, MPH, Department of Pharmaceutical Care and Health Systems, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota.; Angeline Carlson, PhD, Department of Pharmaceutical Care and Health Systems, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota., Norman HS; Shaquib Al Hasan, MS, Social and Administrative Pharmacy Graduate Program, Department of Pharmaceutical Care and Health Systems, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota.; Levi Neal-Herman, MBA, Coloplast Care, Coloplast Corp, Minneapolis, Minnesota.; Holly S. Norman, PhD, Coloplast Corp, Minneapolis, Minnesota.; Julie Z. Zhao, MPH, Department of Pharmaceutical Care and Health Systems, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota.; Angeline Carlson, PhD, Department of Pharmaceutical Care and Health Systems, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota., Zhao JZ; Shaquib Al Hasan, MS, Social and Administrative Pharmacy Graduate Program, Department of Pharmaceutical Care and Health Systems, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota.; Levi Neal-Herman, MBA, Coloplast Care, Coloplast Corp, Minneapolis, Minnesota.; Holly S. Norman, PhD, Coloplast Corp, Minneapolis, Minnesota.; Julie Z. Zhao, MPH, Department of Pharmaceutical Care and Health Systems, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota.; Angeline Carlson, PhD, Department of Pharmaceutical Care and Health Systems, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota., Carlson A; Shaquib Al Hasan, MS, Social and Administrative Pharmacy Graduate Program, Department of Pharmaceutical Care and Health Systems, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota.; Levi Neal-Herman, MBA, Coloplast Care, Coloplast Corp, Minneapolis, Minnesota.; Holly S. Norman, PhD, Coloplast Corp, Minneapolis, Minnesota.; Julie Z. Zhao, MPH, Department of Pharmaceutical Care and Health Systems, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota.; Angeline Carlson, PhD, Department of Pharmaceutical Care and Health Systems, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota.
Publikováno v:
Journal of wound, ostomy, and continence nursing : official publication of The Wound, Ostomy and Continence Nurses Society [J Wound Ostomy Continence Nurs] 2022 Sep-Oct 01; Vol. 49 (5), pp. 470-480.